Hydralazine is an arterial vasodilator traditionally prescribed as an antihypertensive drug. Further studies into the pharmacological properties of this drug have highlighted its potent reno-protective effects. This has led to its use as a potential therapeutic option for patients suffering from acute kidney injury and chronic kidney disease. Its favorable pharmacokinetic properties such as high solubility and long half-life along with its non-dialyzable nature render it a promising therapeutic option in hypertensive patients with renal comorbidities.
To learn more about this, join us for a special session on “ Nephrology Perspectives on the Use of Hydralazine ” with the noted nephrologist Dr Georgy Nainan on 14 th June , 6 PM IST onwards. Stay tuned! ##Disclaimer:## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we…
